About   Help   FAQ
Mammalian Phenotype Ontology Annotations
Query Results - Summary
Symbol
Name
ID 		Pik3ca
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha
MGI:1206581
111 phenotypes from 15 alleles in 20 genetic backgrounds
Export: Excel File
Allelic Composition
Genetic Background		 Annotated Term Reference
Egr2tm2(cre)Pch/Egr2+
Gt(ROSA)26Sortm7(Pik3ca*,EGFP)Rsky/?
involves: 129S2/SvPas * C57BL/6 		abnormal myelination J:207470
Gt(ROSA)26Sortm1(Pik3ca*H1047R)Egan/Gt(ROSA)26Sor+
involves: 129S6/SvEvTac 		abnormal blood vessel morphology J:170898
premature death J:170898
Gt(ROSA)26Sortm1(Pik3ca*H1047R)Egan/Gt(ROSA)26Sor+
involves: 129S6/SvEvTac * CD-1 		abnormal ovary morphology J:219794
normal neoplasm J:219794
Gt(ROSA)26Sortm1(Pik3ca*H1047R)Egan/Gt(ROSA)26Sor+
Tg(MMTV-cre)1Mam/0
involves: 129S6/SvEvTac * FVB/N 		increased mammary gland tumor incidence J:170898
increased tumor incidence J:170898
premature death J:170898
Gt(ROSA)26Sortm1(Pik3ca*H1047R)Egan/Gt(ROSA)26Sor+
Olig2tm1.1(cre)Wdr/Olig2+
involves: 129 * C57BL/6 * FVB/N 		normal neoplasm J:285841
Gt(ROSA)26Sortm1(Pik3ca*H1047R)Egan/Gt(ROSA)26Sor+
Tg(MMTV-cre)#Tfln/0
involves: 129S6/SvEvTac 		increased mammary adenocarcinoma incidence J:170898
increased mammary gland tumor incidence J:170898
increased tumor incidence J:170898
premature death J:170898
Gt(ROSA)26Sortm2(Pik3ca)Egan/Gt(ROSA)26Sor+
Tg(MMTV-cre)1Mam/0
involves: 129S6/SvEvTac * FVB/N 		no abnormal phenotype detected J:170898
Gt(ROSA)26Sortm2(Pik3ca)Egan/Gt(ROSA)26Sor+
Tg(MMTV-cre)#Tfln/0
involves: 129S6/SvEvTac 		no abnormal phenotype detected J:170898
Gt(ROSA)26Sortm2(Pik3ca*)Dsa/Gt(ROSA)26Sor+
Ptf1atm1(cre)Hnak/Ptf1a+
involves: 129S6/SvEvTac 		enlarged pancreas J:197054
increased carcinoma incidence J:197054
increased pancreas weight J:197054
increased pancreatic ductal adenocarcinoma incidence J:197054
increased pancreatic intraepithelial neoplasia incidence J:197054
pancreatic acinar-to-ductal metaplasia J:197054
Gt(ROSA)26Sortm2(Pik3ca*)Dsa/Gt(ROSA)26Sor+
Tg(Cela1-cre/ERT)1Dam/0
involves: 129S6/SvEvTac 		increased pancreatic intraepithelial neoplasia incidence J:197054
pancreatic acinar-to-ductal metaplasia J:197054
Gt(ROSA)26Sortm7(Pik3ca*,EGFP)Rsky/Gt(ROSA)26Sor+
Tg(CAG-cre/Esr1*)5Amc/0
B6.Cg-Gt(ROSA)26Sortm7(Pik3ca*,EGFP)Rsky Tg(CAG-cre/Esr1*)5Amc 		abnormal blood vessel morphology J:264410
abnormal limb morphology J:264410
abnormal spleen morphology J:264410
abnormal vein morphology J:264410
dilated vasculature J:264410
enlarged lymphatic vessel J:264410
hepatic steatosis J:264410
increased cell proliferation J:264410
increased classified tumor incidence J:264410
internal hemorrhage J:264410
kidney cyst J:264410
liver hemorrhage J:264410
postnatal lethality, incomplete penetrance J:264410
premature death J:264410
renal fibrosis J:264410
scoliosis J:264410
skeletal muscle hypertrophy J:264410
visceromegaly J:264410
Gt(ROSA)26Sortm7(Pik3ca*,EGFP)Rsky/Gt(ROSA)26Sortm7(Pik3ca*,EGFP)Rsky
Tg(Cr2-cre)3Cgn/0
involves: C57BL/6 		neonatal lethality, complete penetrance J:157297
Pik3catm1.1Jjz/Pik3catm1.1Jjz
involves: C57BL/6 		abnormal cell physiology J:115274
Pik3catm1.1Rzl/Pik3catm1.1Rzl
A1cfTg(Myh6-cre/Esr1*)1Jmk/A1cf+
involves: 129S4/SvJaeSor * C57BL/6 * FVB/N 		abnormal myocardial fiber physiology J:166421
decreased cardiac muscle contractility J:166421
decreased heart weight J:166421
increased heart left ventricle size J:166421
thick ventricular wall J:166421
Pik3catm1.1Rzl/Pik3catm1.1Rzl
Tg(Fabp4-cre)1Blw/0
involves: 129 * C57BL/6 * FVB/N 		abnormal anogenital distance J:315599
abnormal circulating androgen level J:315599
abnormal hormone level J:315599
abnormal testis physiology J:315599
abnormal white adipose tissue physiology J:315599
decreased circulating luteinizing hormone level J:315599
decreased testis weight J:315599
delayed balanopreputial separation J:315599
delayed sexual maturation J:315599
normal homeostasis/metabolism phenotype J:315599
increased body weight J:315599
increased circulating leptin level J:315599
increased circulating testosterone level J:315599
increased total body fat amount J:315599
male infertility J:315599
normal reproductive system phenotype J:315599
Pik3catm1.1Waph/Pik3ca+
involves: 129S1/Sv * C57BL/6 		abnormal ovary morphology J:184382
decreased fibroblast apoptosis J:184382
increased fibroblast proliferation J:184382
Pik3catm1.1Waph/Pik3ca+
Tg(MMTV-cre)#Mam/0
involves: 129S1/Sv * C57BL/6 * FVB 		abnormal branching of the mammary ductal tree J:187299
abnormal mammary duct terminal end bud morphology J:187299
abnormal mammary gland duct morphology J:187299
abnormal mammary gland epithelium morphology J:187299
abnormal mammary gland myoepithelium morphology J:187299
abnormal mammary gland stroma morphology J:187299
increased fibroadenoma incidence J:187299
increased mammary adenoacanthoma incidence J:187299
increased mammary gland epithelial cell proliferation J:187299
increased mammary gland tumor incidence J:187299
increased osteosarcoma incidence J:187299
increased sarcoma incidence J:187299
premature death J:187299
Pik3catm1Bvan/Pik3ca+
involves: 129P2/OlaHsd 		abnormal angiogenesis J:136236
abnormal retina vasculature morphology J:136236
Pik3catm1Bvan/Pik3ca+
involves: 129P2/OlaHsd * C57BL/6 		decreased body length J:109024
decreased body weight J:109024
decreased lean body mass J:109024
decreased skeletal muscle mass J:109024
fetal growth retardation J:109024
impaired glucose tolerance J:109024
increased circulating insulin level J:109024
increased circulating leptin level J:109024
increased fat cell size J:109024
increased pancreatic beta cell number J:109024
insulin resistance J:109024
polyphagia J:109024
postnatal growth retardation J:109024
Pik3catm1Bvan/Pik3catm1Bvan
involves: 129P2/OlaHsd 		abnormal dorsal aorta morphology J:136236
abnormal intersomitic vessel morphology J:136236
abnormal perineural vascular plexus morphology J:136236
abnormal vascular development J:136236
abnormal vitelline vascular remodeling J:136236
embryonic growth arrest J:136236
embryonic growth retardation J:136236
embryonic lethality, complete penetrance J:136236
internal hemorrhage J:136236
Pik3catm1Bvan/Pik3catm1Bvan
involves: 129P2/OlaHsd * C57BL/6 		embryonic growth retardation J:109024
embryonic lethality during organogenesis, complete penetrance J:109024
Pik3catm1Gilb/Pik3ca+
Not Specified 		normal neoplasm J:186709
Pik3catm1Gne/Pik3ca+
Tg(MMTV-cre)1Mam/0
involves: C57BL/6N * FVB/N 		abnormal branching of the mammary ductal tree J:193377
increased mammary gland tumor incidence J:193377
normal neoplasm J:193377
Pik3catm1Gne/Pik3catm1Gne
involves: C57BL/6N 		normal mortality/aging J:193377
Pik3catm1Jdo/Pik3catm1Jdo
B6.129S7(Cg)-Pik3catm1Jdo 		abnormal lymphangiogenesis J:122866
abnormal lymphatic vessel morphology J:122866
chylous ascites J:122866
decreased body weight J:122866
decreased incidence of tumors by chemical induction J:122866
neonatal lethality, incomplete penetrance J:122866
postnatal lethality, incomplete penetrance J:122866
Pik3catm1Jjz/Pik3catm1Jjz
Tg(OPN1LW-cre)4Yzl/0
involves: 129 * FVB/N 		decreased b-wave amplitude J:282245
retina cone cell degeneration J:282245
Pik3catm1Jjz/Pik3catm1Jjz
Tg(Pbsn-cre)4Prb/0
involves: 129 * C57BL/6 * DBA/2 		abnormal cell physiology J:138565
increased prostate intraepithelial neoplasia incidence J:138565
Pik3catm1Nbm/Pik3catm1Nbm
involves: 129S6/SvEvTac 		abnormal somite development J:54237
decreased cell proliferation J:54237
decreased embryo size J:54237
embryonic lethality during organogenesis, complete penetrance J:54237
hemorrhage J:54237
Pik3catm1Nbm/Pik3catm1Nbm
involves: 129S6/SvEvTac * CD-1 		abnormal anterior cardinal vein morphology J:98972
abnormal brain vasculature morphology J:98972
abnormal endocardium morphology J:98972
abnormal vitelline vasculature morphology J:98972
blood vessel congestion J:98972
embryonic lethality during organogenesis, complete penetrance J:98972
pale yolk sac J:98972
Pik3catm3Bvan/Pik3catm3Bvan
Tg(Tek-cre)1Ywa/0
involves: 129P2/OlaHsd * C57BL/6 * SJL 		abnormal vascular development J:136236
abnormal vitelline vascular remodeling J:136236
embryonic lethality during organogenesis, complete penetrance J:136236
Tg(Amhr2-Pik3ca*,-GFP)#Lzh/0
involves: C3H * C57BL/6 		abnormal ovarian follicle number J:144834
abnormal ovary morphology J:144834
normal neoplasm J:144834
reduced female fertility J:144834
Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support. 		last database update
11/19/2024
MGI 6.24 		The Jackson Laboratory